Article
Pediatric Acute Lymphoblastic Leukemia
1 Jan 2003
Abstract excerpt
The outcome for children with acute lymphoblastic leukemia (ALL) has improved dramatically with current therapy resulting in an event free survival exceeding 75% for most patients. However significant challenges remain including developing better methods to predict which patients can be cured with less toxic treatment and which ones will benefit from augmented therapy. In addition, 25% of patients fail therapy...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.